Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Why, What and When to Image

Imanova’s Kevin Cox wants to raise awareness of the potential for wider imaging applications within pharma, encouraging companies to pursue well-designed PET scan studies earlier in the drug development process.

Kevin Cox, Imanova (March 2015)

Keywords: Clinically validated biomarkers, Positron emission tomography, Experimental medicine, First-in-human studies, Biomathematical modelling, Magnetic resonance imaging

    View full article    |    Back to Analytical Laboratory Technology section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |